Keep Current with the Latest in Cell Biology Research
Block title
Acquired Genetic and Cell-State Changes in IDH-Mutant Glioma Progression
[Nature] Researchers showed that malignant cell states transcriptionally resemble stages of normal glial–neuronal lineage development or a reactive mesenchymal-like state, mirroring states previously described in isocitrate dehydrogenase (IDH) wild-type glioblastoma.
Epigenetic Control of Microglial Mitochondrial Immunity by KAT7 Drives Alzheimer’S Disease Pathogenesis
[Neuron] Investigators identified the histone acetyltransferase KAT7 as a central epigenetic regulator that links chromatin remodeling to mitochondrial immune activation.
IQGAP3 Bridges Matrix Stiffness with Glioma Stem Cell Maintenance and Radioresistance by Stabilizing SOX2
[Nature Communications] Differential gene expression revealed that stiff matrices induce expression of IQ Motif Containing GTPase Activating Protein 3 (IQGAP3) through YAP1 and TEAD transcription factors in GBM stem cells.
Microglial CD31 Suppresses aβ Clearance and Promotes Alzheimer Pathology in 5×FAD Mice
[Nature Communications] The authors showed that CD31, a recognized endothelial marker, is predominantly expressed in microglia but not in neurons or astrocytes, and it is significantly elevated in the brains of Alzheimer’s disease patients and mouse models.
miR-151-5p Regulates Neural Stem Cell Fate by Targeting APH1A to Modulate Notch Signaling Gradients
[Stem Cell Reports] Researchers found miR-151-5p is expressed in neural stem cells (NSCs) of the developing mouse cerebral cortex. Conditional knockout of miR-151-5p increased SOX2 expression in NSCs and enhanced their proliferative capacity.
Overexpression of miR-219 As a Potential Therapeutic Strategy of Glioblastoma Cells In Vitro
[Scientific Reports] Scientists evaluated miR-219 effects on glioblastoma in vitro, in combination with radiation and temozolomide. They indicated that miR-219 may modulate tumor-related processes through the negative regulation of target genes such as REST and AKAP13.
A 2026 Perspective on Neural Stem Cells and Glial Plasticity
[Trends in Cell Biology] Investigators focus particularly on astrocytes and integrate evidence from invertebrate models demonstrating that glial cells possess an intrinsic capacity for neurogenesis.
Necroptosis Triggers Inflammatory Interferon Signatures in Patient-Derived Metastatic Breast Cancer Organoids
[Signal Transduction and Targeted Therapy] Scientists applied 3D patient-derived, metastatic human mammary organoids to model apoptosis resistance, necroptosis, and inflammatory signaling using single-cell CITE-sequencing, time-lapse live cell brightfield, and immunofluorescent confocal microscopy, as well as biochemical approaches.
Commensal Dysbiosis Alters Primary Bile Acid Signaling to Drive Mammary Gland Inflammation and Breast Tumor Dissemination
[Cancer Research] Researchers revealed that commensal dysbiosis-associated loss of microbial bile acid (BA) metabolism elevates primary BAs and promotes HR+ metastatic progression through prostaglandin E2 signaling.
HTRA1+ Macrophages Induce T-Cell Egress through CRIP1/NF-κB/CXCL12 to Limit the Effects of Immunotherapy in Triple-Negative Breast Cancer
[Cancer Immunology Research] Using single-cell and spatial transcriptomes, investigators identified, at the single-cell level, a subpopulation of macrophages related to T cell expansion during immunotherapy, characterized by high expression of high-temperature requirement A1 (HTRA1), and correlated with clinical and immunotherapy outcomes in TNBC.
IRX1 Suppresses Breast Cancer Progression by Inhibiting Fatty Acid De Novo Synthesis through Downregulating ACACA Expression
[Cell Death & Disease] The authors demonstrated that iroquois homeobox 1 (IRX1) is downregulated in breast cancer tissues and cell lines due to promoter hypermethylation.
Red Blood Cell-Derived Extracellular Vesicles Enable Cisplatin and Cetuximab Combined Therapy against Triple-Negative Breast Cancer
[Journal of Nanobiotechnology] Scientists highlighted the potential of red blood cell-derived extracellular vesicles as a biocompatible delivery system enabling combined therapy and offering a promising strategy to overcome current limitations in TNBC treatment.

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
